Pertento Partners LLP Roivant Sciences Ltd. Call Options Transaction History
Pertento Partners LLP
- $583 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
313Shares Held
496MCall Options Held
991KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$823 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$797 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$769 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$408 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$338 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.12B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...